วีรบุรุษสุขภาพ

Personalis is said to have attracted takeover interest from Merck

Johnson & Johnson has a chance to show it's more than just a rotation winner

S&P 500 Moderna Rebound: Can Biotech Strength Cushion the AI Chip Sell-Off?

Bio-Techne jumps after Merck KGaA strikes $11.3B buyout deal

Key deals this week: GSK, Incyte, Ingredion, OpenAI, and more

Merck Animal Health to buy biodevice developer TARGAN

GSK to buy Nuvalent for $10.6B

Merck and Hashgraph Group launch Hedera-based product passport for EU compliance